StockGlow

HBM Holdings Limited (2142.HK)

HBM Holdings Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

12.26-0.01%Healthcare
Compare 2142.HK with
StockGlow Score
54
Neutral
BearishBullish
1 year ago+35.9%

The outlook

HBM Holdings Limited currently reads as neutral based on mixed vs its moving averages, 39% of the way from its 52-week low to high, avg target +63% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendMixed vs its moving averages
52-week range39% of the way from its 52-week low to high
Price targetAvg target +63% vs current price
Market cap
$10.24B
52-wk high
17.98
52-wk low
8.62
50-day avg
11.28
200-day avg
12.53
Trailing P/E
13.0

Similar stocks

2126.HKJW (Cayman) Therapeutics Co. Ltd$1.57+1.95%2137.HKBrii Biosciences Limited$0.96+0.00%2171.HKCARsgen Therapeutics Holdings Limited$13.50+2.43%2096.HKSimcere Pharmaceutical Group Limited$12.86+0.39%2162.HKKeymed Biosciences Inc.$75.25-3.59%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy